Revelo, Yvonnie D.
HRN: 25-54-97 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2024
CEFUROXIME 500MG (TAB)
08/02/2024
08/08/2024
ORAL
500mg
BID
UTI
Waiting Final Action